Tier 2 · Liquid 3000
Tarsus Pharmaceuticals, Inc.
TARS · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$59.85
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001819790
Liquidity rank
#1342
Observed dollar volume
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $451.36M | 2025-12-31 | 0001819790-26-000019 |
| Annual diluted EPS | -1.59 | 2025-12-31 | 0001819790-26-000019 |
| Quarterly revenue | $162.05M | 2026-03-31 | 0001819790-26-000038 |
| Quarterly diluted EPS | -0.16 | 2026-03-31 | 0001819790-26-000038 |
SEC EDGAR Frames batch generated 2026-07-16T23:27:27.089Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Dividends
Trailing 12 months
Not published
Latest payment
Not published
Yahoo Finance corporate actions. Window: 2025-07-18 through 2026-07-18.
Seasonality
| Month | Mean return | Positive | n |
|---|
Monthly close-to-close returns, trailing 15 years where Yahoo history is available.
Sector news
No matching sector headlines were returned in the 72-hour window.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames